Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Melanoma
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Melanoma
    TopAbstracts in Melanoma 11/18/2009 - (DGNews)
    Proton Beam Radiation Therapy for Uveal Melanoma Yields Good Results at a Dose of 56 Gy: Presented at ASTRO - (DGDispatch)
    TopAbstracts in Melanoma 10/21/2009 - (DGNews)
    TopAbstracts in Melanoma 09/23/2009 - (DGNews)
    Study Reveals New Genetic Mutations Involved in Melanoma - (DGNews)

    News archive

     Recent webcasts/CME - Melanoma
    • Moving Beyond Standard Therapy in Malignant Melanoma: Novel Agents and Combinations
    • Adjuvant Interferon Therapy Prolongs Relapse-Free Interval and Survival in Melanoma
    • Rational Vaccine Strategies May Better Harness the Immune System for Anticancer Response in Melanoma
    • Response May Not Be an Appropriate Endpoint for Evaluating Benefit From CTLA-4 Antagonists in Melanoma
    • Emerging Strategies for the Treatment of Metastatic Melanoma: The Role of Monoclonal Antibodies in Targeted Immunotherapy

      Webcasts/CME archive

       Recent cases - Melanoma
        Metastatic Melanoma Presenting as a Thyroid Nodule in a 38-Year-Old Woman
        Diffuse Anorectal Melanoma; Review of the Current Diagnostic and Treatment Aspects Based on a Case Report
        Malignant Melanoma Associated with a Blue Naevus: A Case Report
        Metastatic Malignant Melanoma of the Conjunctiva: A Case Report
        Delayed Malignant Melanoma Recurrence Simulating Primary Ovarian Cancer

        Cases archive
          




        my personal edition > melanoma > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Study Shows Foot Melanoma Survival Rate Is Just 1 in 2

        PARK RIDGE, IL -- August 19, 2003 -- Malignant melanoma is increasing faster than any cancer, and a new study in the current issue of the Journal of Foot and Ankle Surgery shows the overall five-year survival rate for melanoma of the foot and ankle is significantly lower than for melanomas found elsewhere.

        In the United States, some 40,000 new cases of malignant melanoma are diagnosed every year and the disease accounts for up to 10,000 deaths annually. Melanoma is the most common foot malignancy and is more likely to be misdiagnosed than a melanoma located elsewhere, according to lead author Susan M. Walsh, DPM, AACFAS, a podiatric foot and ankle surgeon in Rhode Island. Her data showed that the overall five-year survival rate was 52 percent for patients with a primary melanoma of the foot or ankle compared to 84 percent for patients with melanoma on the thigh or calf.

        "The results of this study should be a strong reminder for physicians and patients to be vigilant in checking the feet carefully for evidence of skin cancer," said Walsh. "A malignant melanoma on the foot, especially if it isn't painful and on the bottom of the foot, won't be as readily noticed as a lesion on the face or arm. Foot melanomas, therefore, are more advanced and more dangerous when they are diagnosed and treated," she added.

        Melanomas can be found anywhere on the foot, including under a toenail. They most often appear as pigmented lesions. Risk factors are similar to other skin cancers, such as excessive unprotected sun exposure, family history of skin cancer, numerous moles on the body and having fair skin, blue eyes or red hair. However, populations normally at low risk for skin cancer, such as blacks, Hispanics and Asians, also can develop melanomas on their feet.

        Walsh advises physicians to be highly suspicious whenever a patient has a pigmented or unusual lesion on the foot. To be safe, anyone with moles on their feet should watch them carefully and have them removed and biopsied by a podiatric foot and ankle surgeon if they change in color and shape. The Journal of Foot & Ankle Surgery is published by the American College of Foot and Ankle Surgeons, 1-888-THE FEET, http://www.acfas.org.


        SOURCE: American College of Foot and Ankle Surgeons



        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send